DE69322092D1 - Neue bakterielle impfstoffe unter verwendung von impfstämmen von pathogenen bakterien - Google Patents

Neue bakterielle impfstoffe unter verwendung von impfstämmen von pathogenen bakterien

Info

Publication number
DE69322092D1
DE69322092D1 DE69322092T DE69322092T DE69322092D1 DE 69322092 D1 DE69322092 D1 DE 69322092D1 DE 69322092 T DE69322092 T DE 69322092T DE 69322092 T DE69322092 T DE 69322092T DE 69322092 D1 DE69322092 D1 DE 69322092D1
Authority
DE
Germany
Prior art keywords
pathogenic bacteria
vaccine strains
mutation
new bacterial
bacterial vaccines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69322092T
Other languages
English (en)
Other versions
DE69322092T2 (de
Inventor
Brenda J Allan
Andrew A Potter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Saskatchewan
Original Assignee
University of Saskatchewan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Saskatchewan filed Critical University of Saskatchewan
Publication of DE69322092D1 publication Critical patent/DE69322092D1/de
Application granted granted Critical
Publication of DE69322092T2 publication Critical patent/DE69322092T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE69322092T 1992-09-04 1993-09-03 Neue bakterielle impfstoffe unter verwendung von impfstämmen von pathogenen bakterien Expired - Fee Related DE69322092T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US93949692A 1992-09-04 1992-09-04
US11568393A 1993-09-03 1993-09-03
PCT/CA1993/000365 WO1994005326A1 (en) 1992-09-04 1993-09-03 Novel bacterial vaccines using vaccine strains of pathogenic bacteria

Publications (2)

Publication Number Publication Date
DE69322092D1 true DE69322092D1 (de) 1998-12-17
DE69322092T2 DE69322092T2 (de) 1999-07-15

Family

ID=26813454

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69322092T Expired - Fee Related DE69322092T2 (de) 1992-09-04 1993-09-03 Neue bakterielle impfstoffe unter verwendung von impfstämmen von pathogenen bakterien

Country Status (7)

Country Link
US (1) US5747309A (de)
EP (1) EP0659086B1 (de)
AT (1) ATE173166T1 (de)
AU (1) AU683221B2 (de)
CA (1) CA2143299A1 (de)
DE (1) DE69322092T2 (de)
WO (1) WO1994005326A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2265643T3 (es) * 1994-04-11 2007-02-16 Wyeth Holdings Corporation Bacteria de borrelia burgdorferi.
EP0973865A2 (de) * 1997-04-11 2000-01-26 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Abgeschwächte, invasive impfstoffe gegen fischpathogenen
US6010705A (en) * 1997-04-11 2000-01-04 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Attenuated, invasive vaccines against fish pathogens
GB9711964D0 (en) * 1997-06-09 1997-08-06 Medical Res Council Live attenuated vaccines
US6153202A (en) * 1998-03-06 2000-11-28 The United States Of America As Represented By The Secretary Of Agriculture In ovo methods for utilizing live Edwardsiella ictaluri against enteric septicemia in channel catfish
US6019981A (en) * 1998-03-06 2000-02-01 The United States Of America As Represented By The Secretary Of Agriculture Modified live Edwardsiella ictaluri against enteric septicemia in channel catfish
US20020081317A1 (en) * 1999-02-02 2002-06-27 Mahan Michael J. Bacteria with altered DNA adenine methylase (DAM) activity and heterologous epitope
EP1069133A1 (de) * 1999-07-13 2001-01-17 Institut National De La Sante Et De La Recherche Medicale (Inserm) Neisseria meningitidis Zusammensetzungen und ihre Verwendungen als anti-infektionsmitteln
US7300659B2 (en) * 2001-01-04 2007-11-27 University Of Saskatchewan Enterohemorrhagic Escherichia coli vaccine
US7763451B2 (en) 2001-11-09 2010-07-27 The United States Of America As Represented By The Department Of Health And Human Services Methods for preparing Bacillus anthracis protective antigen for use in vaccines
EP2380440B1 (de) * 2002-04-15 2016-03-09 Washington University Geregelte Abschwächung von lebenden Impfstoffen zur Verbesserung der gekreuzten Schutzimmunogenität
US7334538B1 (en) * 2004-07-27 2008-02-26 Aquascience Research Group, Inc. Topical medicants for aquatic animals
GB0511203D0 (en) * 2005-06-02 2005-07-06 Univ Birmingham Vaccines
US20110129438A1 (en) * 2006-06-28 2011-06-02 James Robert Swartz Immunogenic protein constructs
PL2066339T3 (pl) 2006-09-18 2015-02-27 Univ Arkansas Kompozycje i sposoby zwiększania odpowiedzi immunologicznych
NZ585776A (en) * 2007-10-30 2012-07-27 Univ Arkansas Compositions and methods of enhancing immune responses to flagellated bacterium
CA3051748C (en) 2007-11-01 2022-07-12 The Board Of Trustees Of The University Of Arkansas Compositions and methods of enhancing immune responses to eimeria
MX341775B (es) 2010-01-21 2016-09-02 The Texas A&M Univ System * Vectores para vacunas y metodos para potenciar respuestas inmunes.
KR102008120B1 (ko) 2010-06-09 2019-08-07 더 보드 오브 트러스티스 오브 더 유니버시티 오브 아칸소 캄필로박터 감염을 감소시키기 위한 백신 및 방법
US9200251B1 (en) 2011-03-31 2015-12-01 David Gordon Bermudes Bacterial methionine analogue and methionine synthesis inhibitor anticancer, antiinfective and coronary heart disease protective microcins and methods of treatment therewith
HUE047484T2 (hu) 2013-02-14 2020-04-28 Univ Arkansas Készítmények és eljárások eimeria elleni immunválasz fokozására vagy eimeria-fertõzés korlátozására
JP6530742B2 (ja) 2013-03-15 2019-06-12 ザ ボード オブ トラスティーズ オブ ザ ユニバーシティ オブ アーカンソー 腸内病原体の免疫応答を強化する組成物及び方法
TWI843057B (zh) 2016-05-03 2024-05-21 阿肯色州大學董事會 包含免疫刺激性及抗原性多肽的酵母菌疫苗載體以及其使用方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1472624A (en) * 1974-09-02 1977-05-04 Canadian Patents Dev Enteric disease vaccine
US4190495A (en) * 1976-09-27 1980-02-26 Research Corporation Modified microorganisms and method of preparing and using same
IL59663A (en) * 1980-03-19 1983-02-23 Univ Ramot Vaccines obtained from bacterial mutant strains of enterobacteriaceae and pseudomonaceae
US5210035A (en) * 1980-05-19 1993-05-11 Board Of Trustees Of Leland Stanford Jr. University Non-reventing live vaccines
US5077044A (en) * 1980-05-19 1991-12-31 The Board Of Trustees Of The Leland Stanford Jr. University Novel non-reverting shigella live vaccines
US4888170A (en) * 1981-10-22 1989-12-19 Research Corporation Vaccines obtained from antigenic gene products of recombinant genes
FR2644346B1 (fr) * 1989-03-20 1994-05-13 Rhone Merieux Vaccins contre les bacteries septicemiques, preparations d'antigenes de bacteries septicemiques, nouvelles bacteries et vecteurs pour la preparation de ces antigenes ou vaccins
ATE167061T1 (de) * 1989-11-03 1998-06-15 Univ Washington Kreuzschützende salmonella impfstoffe
US5213972A (en) * 1989-12-08 1993-05-25 Chemgen Corporation Fermentation process for the production of pyrimidine deoxyribonucleosides
GB9007194D0 (en) * 1990-03-30 1990-05-30 Wellcome Found Live vaccines
DE69132058D1 (de) * 1990-12-18 2000-04-20 Gen Hospital Corp Verbesserte impfstoffe
AU1229492A (en) * 1991-01-29 1992-08-27 Regents Of The University Of Minnesota Live vaccine against colibacillosis

Also Published As

Publication number Publication date
EP0659086A1 (de) 1995-06-28
DE69322092T2 (de) 1999-07-15
US5747309A (en) 1998-05-05
CA2143299A1 (en) 1994-03-17
AU683221B2 (en) 1997-11-06
AU4939193A (en) 1994-03-29
ATE173166T1 (de) 1998-11-15
WO1994005326A1 (en) 1994-03-17
EP0659086B1 (de) 1998-11-11

Similar Documents

Publication Publication Date Title
ATE173166T1 (de) Neue bakterielle impfstoffe unter verwendung von impfstämmen von pathogenen bakterien
WO1998056901A3 (en) Live attenuated vaccines
DE3878468D1 (de) Chimarenglykoproteine, enthaltend immunogene segmente des humanen respiratorischen synzytialvirus.
ATE219948T1 (de) Rekombinante impfstoffe die immunogene attenuierte rpos-positiv phentotyp bakterien enthalten
ATE454163T1 (de) Bakterielle impfstoffe, enthaltend auxotrophe attenuierte listerienstämme, welche heterologe antigene exprimieren
DK251890D0 (da) Polypeptid og dets anvendelse samt ekspressionssystem til dets eksprimering
UA40571C2 (uk) Мутант коров'ячого вірусу герпесу типу 1 (bhv-1), композиція вакцини для вакцинації тварин для захисту їх від bhv-1, композиція вакцини для вакцинації тварин для захисту їх від патогена
BG106365A (en) Herbicidal agents containing post-emergence herbicides for soil application
HU0005010D0 (de)
NO20004781D0 (no) Svekkede bakterier anvendelige i vaksiner
PT600396E (pt) Vacinas contra protozoarios intestinais
YU49995A (sh) Polinukleotidna vakcina za virus herpesa
DK1074266T3 (da) Levende svækkede bakterier til anvendelse i vaccine
CA2097702A1 (en) Dermatomycosis vaccine
WO2000045840A8 (en) Compositions and methods for treating and preventing pathogenic bacterial infection based on the essential role of dna methylation in bacterial virulence
ATE16348T1 (de) Ozon-inaktivierte keime als vakzine.
FR2809960B1 (fr) Composition adjuvante de la reponse immunitaire comprenant la proteine fha ou un fragment de la proteine fha sous forme libre, et composition immunogene ou vaccinale contenant une telle composition adjuvante
AU1853995A (en) Vaccine compositions
DE69826712D1 (de) Impfstoffe die abgeschwächte bakterien enthalten
Abbott et al. Evaluation of a new selective agar, thiosulfate-chloride-iodide(TCI), for the growth of pathogenic Vibrio species

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee